| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/B914751A |
| P698 | PubMed publication ID | 20567771 |
| P2093 | author name string | Xin Lu | |
| Peng Gao | |||
| Xiang Li | |||
| Guowang Xu | |||
| Hongwei Kong | |||
| Fengxia Zhang | |||
| Zhenhua Jia | |||
| Yiling Wu | |||
| P2860 | cites work | Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach | Q33301559 |
| Acylcarnitine deficiency in chronic fatigue syndrome | Q34338925 | ||
| P433 | issue | 5 | |
| P921 | main subject | ion trap | Q202012 |
| P304 | page(s) | 852-861 | |
| P577 | publication date | 2010-02-09 | |
| P1433 | published in | Molecular BioSystems | Q3319467 |
| P1476 | title | Metabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry | |
| P478 | volume | 6 |
| Q48071137 | A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD). |
| Q38071001 | An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies |
| Q48001597 | Biochemical effects of venlafaxine on astrocytes as revealed by 1H NMR-based metabolic profiling |
| Q40130192 | Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase |
| Q36508139 | Identification and validation of urinary metabolite biomarkers for major depressive disorder |
| Q48214945 | Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disorders |
| Q35157192 | Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression. |
| Q37329146 | Microbial-mammalian cometabolites dominate the age-associated urinary metabolic phenotype in Taiwanese and American populations |
| Q21559605 | Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway |
| Q30801268 | Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder |
| Q26786208 | Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression |
| Q48509764 | Separation of Key Biogenic Amines by Capillary Electrophoresis and Determination of Possible Indicators of Sport Fatigue in Athlete's Urine. |
| Q36897172 | Serum metabolite profiles of postoperative fatigue syndrome in rat following partial hepatectomy |
| Q33614561 | Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats |
| Q46392397 | The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk |
| Q33679513 | The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis |
| Q99609834 | Untargeted Metabolomic Profiling Using UHPLC-QTOF/MS Reveals Metabolic Alterations Associated with Autism |
| Q49057114 | Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography-mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer. |
| Q28083512 | What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders? |
Search more.